Cerebroprotective action of angiotensin peptides in stroke

Clinical Science

Volumn 126, Issue 3, 2014, Pages 195-205

  Regenhardt, Robert W ^a   Bennion, Douglas M ^a   Sumners, Colin ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Angiotensin; Inflammation; Mas receptor; Renin; Renin angiotensin system (ras); Stroke

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN[1-7]; CHEMOKINE RECEPTOR CXCR4; COLLAGENASE; CYCLOOXYGENASE 2; DIMINAZENE ACETURATE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; RECEPTOR MAS; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOPHAGY; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN PROTECTION; CARDIOVASCULAR RISK; CELL REGENERATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); ENZYME PHOSPHORYLATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE; LASER DOPPLER FLOWMETRY; MICROGLIA; MIDDLE CEREBRAL ARTERY; NERVE CELL DIFFERENTIATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TIGHT JUNCTION; UPREGULATION;

ANGIOTENSIN I; ANIMALS; HUMANS; PEPTIDE FRAGMENTS; PEPTIDES; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RENIN-ANGIOTENSIN SYSTEM; STROKE; TRANSLATIONAL MEDICAL RESEARCH; VASODILATOR AGENTS;

EID: 84885926657     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130324     Document Type: Review

References (127)

1. Smith, Jr, S. C (2011) Reducing the global burden of ischemic heart disease and stroke: a challenge for the cardiovascular community and the united nations. Circulation 124, 278-279
2. Doyle, K. P., Simon, R. P. and Stenzel-Poore, M. P. (2008) Mechanisms of ischemic brain damage. Neuropharmacology 55, 310-318
3. Candelario-Jalil, E. (2009) Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr. Opin. Investig. Drugs 10, 644-654
4. Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., Degraba, T. J., Gorelick, P. B., Guyton, J. R. et al. (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group; the American Academy of Neurology affirms the value of this guideline. Stroke 37, 1583-1633
5. Paul, M., Poyan Mehr, A. and Kreutz, R. (2006) Physiology of local renin-angiotensin systems. Physiol. Rev. 86, 747-803
6. Page, I. H. and Helmer, O. M. (1940) A crystalline pressor substance (angiotonin) resulting from the reaction between renin and renin-activator. J. Exp. Med. 71, 29-42
7. Braun-Menendez, E., Fasciolo, J. C., Leloir, L. F. and Munoz, J. M. (1940) The substance causing renal hypertension. J. Physiol. 98, 283-298
8. Steckelings, U. M., Rompe, F., Kaschina, E. and Unger, T. (2009) The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam. Clin. Pharmacol. 23, 693-703
9. Ferreira, A. J., Santos, R. A., Bradford, C. N., Mecca, A. P., Sumners, C., Katovich, M. J. and Raizada, M. K. (2010) Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension 55, 207-213
10. Kagiyama, T., Kagiyama, S. and Phillips, M. I. (2003) Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats. Regul. Pept. 110, 241-247
11. Bestehorn, K. and Wahle, K. (2007) Impact of losartan on stroke risk in hypertensive patients in primary care. Clin. Drug Invest. 27, 347-355
12. Dahlof, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O. et al. (2002) Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359, 995-1003
13. Dai, W. J., Funk, A., Herdegen, T., Unger, T. and Culman, J. (1999) Blockade of central angiotensin AT1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 30, 2391-2398
14. Stier, Jr, C. T., Adler, L. A., Levine, S. and Chander, P. N. (1993) Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J. Hypertens. 11, S37-S42
15. Inada, Y., Wada, T., Ojima, M., Sanada, T., Shibouta, Y., Kanagawa, R., Ishimura, Y., Fujisawa, Y. and Nishikawa, K. (1997) Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin. Exp. Hypertens. 19, 1079-1099
16. Nishimura, Y., Ito, T. and Saavedra, J. M. (2000) Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31, 2478-2486
17. Ito, T., Yamakawa, H., Bregonzio, C., Terron, J. A., Falcon-Neri, A. and Saavedra, J. M. (2002) Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke 33, 2297-2303
18. Groth, W., Blume, A., Gohlke, P., Unger, T. and Culman, J. (2003) Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J. Hypertens. 21, 2175-2182
19. Lu, Q., Zhu, Y. Z. and Wong, P. T. (2005) Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats. NeuroReport 16, 1963-1967
20. Li, J., Culman, J., Hortnagl, H., Zhao, Y., Gerova, N., Timm, M., Blume, A., Zimmermann, M., Seidel, K., Dirnagl, U. et al. (2005) Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 19, 617-619
21. Mecca, A. P., O'Connor, T. E., Katovich, M. J. and Sumners, C. (2009) Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion. Exp. Physiol. 94, 937-946
22. Walther, T., Olah, L., Harms, C., Maul, B., Bader, M., Hörtnagl, H., Schultheiss, H. P. and Mies, G. (2002) Ischemic injury in experimental stroke depends on angiotensin II. FASEB J. 16, 169-176
23. Krikov, M., Thone-Reineke, C., Muller, S., Villringer, A. and Unger, T. (2008) Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats. J. Hypertens. 26, 544-552
24. Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T., Niklason, A., Luomanmäki, K., Dahlöf, B., de Faire, U., Mörlin, C. et al. (1999) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project (CAPPP) randomised trial. Lancet 353, 611-616
25. Papademetriou, V., Farsang, C., Elmfeldt, D., Hofman, A., Lithell, H., Olofsson, B., Skoog, I., Trenkwalder, P. and Zanchetti, A. (2004) Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the study on cognition and prognosis in the elderly (SCOPE). J. Am. Coll. Cardiol. 44, 1175-1180
26. Iwai, M., Liu, H. W., Chen, R., Ide, A., Okamoto, S., Hata, R., Sakanaka, M., Shiuchi, T. and Horiuchi, M. (2004) Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 110, 843-848
27. McCarthy, C. A., Vinh, A., Callaway, J. K. and Widdop, R. E. (2009) Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke 40, 1482-1489
28. Carey, R. M. (2005) Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. Hypertension 45, 840-844
29. Viswanathan, M. and Saavedra, J. M. (1992) Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing. Peptides 13, 783-786
30. Makino, I., Shibata, K., Ohgami, Y., Fujiwara, M. and Furukawa, T. (1996) Transient upregulation of the AT2 receptor mRNA level after global ischemia in the rat brain. Neuropeptides 30, 596-601
31. Horiuchi, M., Akishita, M. and Dzau, V. J. (1999) Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 33, 613-621
32. Lucius, R., Gallinat, S., Rosenstiel, P., Herdegen, T., Sievers, J. and Unger, T. (1998) The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J. Exp. Med. 188, 661-670
33. Cote, F., Do, T. H., Laflamme, L., Gallo, J. M. and Gallo-Payet, N. (1999) Activation of the AT2 receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. J. Biol. Chem. 274, 31686-31692
34. Reinecke, K., Lucius, R., Reinecke, A., Rickert, U., Herdegen, T. and Unger, T. (2003) Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-κB. FASEB J. 17, 2094-2096
35. Joseph, J. P., Regenhardt, R. W., Patel, N. A., Mecca, A. P., Steckelings, U. M., Unger, T., Katovich, M. J. and Sumners, C. (2011) Peripheral, post-stroke administration of AT2R agonist compound 21 elicits cerebroprotective effects in ischemic stroke. Neuroscience 2011 Meeting, Washington, D.C., U.S.A. 12-16, November 2012, Abstract 673.03
36. Lee, S., Brait, V. H., Arumugam, T. V., Evans, M. A., Kim, H. A., Widdop, R. E., Drummond, G. R., Sobey, C. G. and Jones, E. S. (2012) Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo. Exp. Transl. Stroke Med. 4, 16
37. Raizada, M. K. and Ferreira, A. J. (2007) ACE2: A new target for cardiovascular disease therapeutics. J. Cardiovasc. Pharmacol. 50, 112-119
38. Grobe, J. L., Mecca, A. P., Lingis, M., Shenoy, V., Bolton, T. A., Machado, J. M., Speth, R. C., Raizada, M. K. and Katovich, M. J. (2007) Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am. J. Physiol. Heart Circ. Physiol. 292, H736-H342
39. Grobe, J. L., Mecca, A. P., Mao, H. and Katovich, M. J. (2006) Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am. J. Physiol. Heart Circ. Physiol. 290, H2417-H2423
40. Huentelman, M. J., Grobe, J. L., Vazquez, J., Stewart, J. M., Mecca, A. P., Katovich, M. J., Ferrario, C. M. and Raizada, M. K. (2005) Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Exp. Physiol. 90, 783-790
41. Ferreira, A. J., Jacoby, B. A., Araujo, C. A., Macedo, F. A., Silva, G. A., Almeida, A. P., Caliari, M. V. and Santos, R. A. (2007) The nonpeptide angiotensin-(1-7) receptor mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 292, H1113-H1119
42. Ferreira, A. J., Shenoy, V., Yamazato, Y., Sriramula, S., Francis, J., Yuan, L., Castellano, R. K., Ostrov, D. A., Oh, S. P., Katovich, M. J. et al. (2009) Evidence for angiotensin-converting enzyme as a therapeutic target for the prevention of pulmonary hypertension. Am. J. Respir. Crit. Care Med. 179, 1048-1054
43. Ferreira, A. J., Santos, R. A. and Almeida, A. P. (2001) Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 38, 665-668
44. Santos, R. A., Ferreira, A. J., Nadu, A. P., Braga, A. N., de Almeida, A. P., Campagnole-Santos, M. J., Baltatu, O., Iliescu, R., Reudelhuber, T. L. and Bader, M. (2004) Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats. Physiol. Genomics 17, 292-299
45. Petty, W. J., Miller, A. A., McCoy, T. P., Gallagher, P. E., Tallant, E. A. and Torti, F. M. (2009) Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone. Clin. Cancer Res. 15, 7398-7404
46. Passos-Silva, D. G., Verano-Braga, T. and Santos, R. A. (2013) Angiotensin-(1-7): beyond the cardio-renal actions. Clin. Sci. 124, 443-456
47. Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G. and Turner, A. J. (2000) A human homolog of angiotensinconverting enzyme. cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275, 33238-33243
48. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R. et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, E1-E9
49. Santos, R. A., Simoes e Silva, A. C., Maric, C., Silva, D. M., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V., Lopes, M. T., Bader, M. et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263
50. Kostenis, E., Milligan, G., Christopoulos, A., Sanchez-Ferrer, C. F., Heringer-Walther, S., Sexton, P. M., Gembardt, F., Kellett, E., Martini, L., Vanderheyden, P. et al. (2005) G-protein-coupled receptor mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111, 1806-1813
51. Castro, C. H., Santos, R. A., Ferreira, A. J., Bader, M., Alenina, N. and Almeida, A. P. (2005) Evidence for a functional interaction of the angiotensin-(1-7) receptor mas with AT1 and AT2 receptors in the mouse heart. Hypertension 46, 937-942
52. Sampaio, W. O., Souza dos Santos, R. A., Faria-Silva, R., da Mata Machado, L. T., Schiffrin, E. L. and Touyz, R. M. (2007) Angiotensin-(1-7) through receptor mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49, 185-192
53. Tallant, E. A., Ferrario, C. M. and Gallagher, P. E. (2005) Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am. J. Physiol. Heart Circ. Physiol. 289, H1560-H1566
54. Su, Z., Zimpelmann, J. and Burns, K. D. (2006) Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int. 69, 2212-2218
55. Sampaio, W. O., Henrique de Castro, C., Santos, R. A., Schiffrin, E. L. and Touyz, R. M. (2007) Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 50, 1093-1098
56. Bunnemann, B., Fuxe, K., Metzger, R., Mullins, J., Jackson, T. R., Hanley, M. R. and Ganten, D. (1990) Autoradiographic localization of mas proto-oncogene mRNA in adult rat brain using in situ hybridization. Neurosci. Lett. 114, 147-153
57. Martin, K. A., Grant, S. G. and Hockfield, S. (1992) The mas proto-oncogene is developmentally regulated in the rat central nervous system. Dev. Brain Res. 68, 75-82
58. Metzger, R., Bader, M., Ludwig, T., Berberich, C., Bunnemann, B. and Ganten, D. (1995) Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett. 357, 27-32
59. Young, D., O'Neill, K., Jessell, T. and Wigler, M. (1988) Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain. Proc. Natl. Acad. Sci. U.S.A. 85, 5339-5342
60. Kumar, M., Grammas, P., Giacomelli, F. and Wiener, J. (1996) Selective expression of c-mas proto-oncogene in rat cerebral endothelial cells. NeuroReport 8, 93-96
61. Becker, L. K., Etelvino, G. M., Walther, T., Santos, R. A. and Campagnole-Santos, M. J. (2007) Immunofluorescence localization of the receptor mas in cardiovascular-related areas of the rat brain. Am. J. Physiol. Heart Circ. Physiol. 293, H1416-H1424
62. Freund, M., Walther, T. and von Bohlen und Halbach, O. (2012) Immunohistochemical localization of the angiotensin-(1-7) receptor mas in the murine forebrain. Cell Tissue Res. 348, 29-35
63. Regenhardt, R. W., Desland, F., Mecca, A. P., Pioquinto, D. J., Afzal, A., Mocco, J. and Sumners, C. (2013) Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke. Neuropharmacology 71, 154-163
64. Harmer, D., Gilbert, M., Borman, R. and Clark, K. L. (2002) Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 532, 107-110
65. Hamming, I., Timens, W., Bulthuis, M. L., Lely, A. T., Navis, G. J. and van Goor, H. (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631-637
66. Gallagher, P. E., Chappell, M. C., Ferrario, C. M. and Tallant, E. A. (2006) Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am. J. Physiol. Cell. Physiol. 290, C420-C426
67. Doobay, M. F., Talman, L. S., Obr, T. D., Tian, X., Davisson, R. L. and Lazartigues, E. (2007) Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R373-R381
68. Mecca, A. P., Regenhardt, R. W., O'Connor, T. E., Joseph, J. P., Raizada, M. K., Katovich, M. J. and Sumners, C. (2011) Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol. 96, 1084-1096
69. Jiang, T., Gao, L., Shi, J., Lu, J., Wang, Y. and Zhang, Y. (2013) Angiotensin-(1-7) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats. Pharmacol. Res. 67, 84-93
70. Regenhardt, R. W., Ritucci-Chinni, P., Desland, F., Mecca, A. P. and Sumners, C. (2011) Angiotensin-(1-7) increases survival of stroke-prone spontaneously hypertensive rats. FASEB J 25, 650.10
71. Del Bigio, M. R., Yan, H. J., Buist, R. and Peeling, J. (1996) Experimental intracerebral hemorrhage in rats: magnetic resonance imaging and histopathological correlates. Stroke 27, 2312-2319
72. Brouns, R. and De Deyn, P. P. (2009) The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg. 111, 483-495
73. Iadecola, C., Zhang, F., Xu, S., Casey, R. and Ross, M. E. (1995) Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J. Cereb. Blood Flow Metab. 15, 378-384
74. Iadecola, C., Zhang, F. and Xu, X. (1995) Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268, R286-R292
75. Iadecola, C., Zhang, F., Casey, R., Nagayama, M. and Ross, M. E. (1997) Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17, 9157-9164
76. Xue, M. and Del Bigio, M. R. (2000) Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci. Lett. 283, 230-232
77. Enzmann, D. R., Britt, R. H., Lyons, B. E., Buxton, J. L. and Wilson, D. A. (1981) Natural history of experimental intracerebral hemorrhage: sonography, computed tomography and neuropathology. AJNR Am. J. Neuroradiol. 2, 517-526
78. Jenkins, A., Maxwell, W. L. and Graham, D. I. (1989) Experimental intracerebral haematoma in the rat: sequential light microscopical changes. Neuropathol. Appl. Neurobiol. 15, 477-486
79. Gong, C., Hoff, J. T. and Keep, R. F. (2000) Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res. 871, 57-65
80. Gong, Y., Hua, Y., Keep, R. F., Hoff, J. T. and Xi, G. (2004) Intracerebral hemorrhage: effects of aging on brain edema and neurological deficits. Stroke 35, 2571-2575
81. Wang, J., Rogove, A. D., Tsirka, A. E. and Tsirka, S. E. (2003) Protective role of tuftsin fragment 1-3 in an animal model of intracerebral hemorrhage. Ann. Neurol. 54, 655-664
82. Wang, J. and Tsirka, S. E. (2005) Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke 36, 613-618
83. Lee, J. M., Yin, K. J., Hsin, I., Chen, S., Fryer, J. D., Holtzman, D. M., Hsu, C. Y. and Xu, J (2003) Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy. Ann. Neurol. 54, 379-382
84. Wang, J. and Tsirka, S. E. (2005) Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain 128, 1622-1633
85. Tang, J., Liu, J., Zhou, C., Alexander, J. S., Nanda, A., Granger, D. N. and Zhang, J. H. (2004) Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice. J. Cereb. Blood Flow Metab. 24, 1133-1145
86. Correale, J. and Villa, A. (2004) The neuroprotective role of inflammation in nervous system injuries. J. Neurol. 251, 1304-1316
87. da Silveira, K. D., Coelho, F. M., Vieira, A. T., Sachs, D., Barroso, L. C., Costa, V. V., Bretas, T. L., Bader, M., de Sousa, L. P., da Silva, T. A. et al. (2010) Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J. Immunol. 185, 5569-5576
88. Giani, J. F., Munoz, M. C., Pons, R. A., Cao, G., Toblli, J. E., Turyn, D. and Dominici, F. P. (2011) Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 300, F272-F282
89. Tesanovic, S., Vinh, A., Gaspari, T. A., Casley, D. and Widdop, R. E. (2010) Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 30, 1606-1613
90. El-Hashim, A. Z., Renno, W. M., Raghupathy, R., Abduo, H. T., Akhtar, S. and Benter, I. F. (2012) Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways. Br. J. Pharmacol. 166, 1964-1976
91. Wösten-van Asperen, R. M., Lutter, R., Specht, P. A., Moll, G. N., van Woensel, J. B., van der Loos, C. M., van Goor, H., Kamilic, J., Florquin, S. and Bos, A. P. (2011) Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J. Pathol. 225, 618-627
92. Regenhardt, R. W., Mecca, A. P., Desland, F., Ritucci, P. and Sumners, C. (2010) Angiotensin-(1-7) reduces cerebral cortical iNOS expression in ischemic stroke: possible mechanism for cerebrotection? Neuroscience 2010 Meeting, San Diego, CA, U.S.A. 13-17 October 2010, Abstract 658.7/Q9
93. Jiang, T., Gao, L., Guo, J., Lu, J., Wang, Y. and Zhang, Y. (2012) Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia. Br. J. Pharmacol. 167, 1520-1532
94. Jiang, T., Gao, L., Zhu, X. C., Yu, J. T., Shi, J. Q., Tan, M. S., Lu, J., Tan, L. and Zhang, Y. D. (2013) Angiotensin-(1-7) inhibits autophagy in the brain of spontaneously hypertensive rats. Pharmacol. Res. 71, 61-68
95. Gao, L., Jiang, T., Guo, J., Liu, Y., Cui, G., Gu, L., Su, L. and Zhang, Y. (2012) Inhibition of autophagy contributes to ischemic postconditioning-induced neuroprotection against focal cerebral ischemia in rats. PLoS ONE 7, e46092
96. Wei, N., Yu, S. P., Gu, X. H., Chen, D. D., Whalin, M. K., Xu, G. L., Liu, X. F. and Wei, L. (2013) The involvement of autophagy pathway in exaggerated ischemic brain damage in diabetic mice. CNS Neurosci. Ther., doi: 10.1111/cns.12123
97. Jauch, E. C., Saver, J. L., Adams, Jr., H. P., Bruno, A., Connors, J. J., Demaerschalk, B. M., Khatri, P., McMullan, Jr., P. W., Qureshi, AI., Rosenfield, K. et al. (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 44, 870-947
98. Botelho-Santos, G. A., Bader, M., Alenina, N. and Santos, R. A. (2012) Altered regional blood flow distribution in mas-deficient mice. Ther. Adv. Cardiovasc. Dis. 6, 201-211
99. Zhang, Y., Lu, J., Shi, J., Lin, X., Dong, J., Zhang, S., Liu, Y. and Tong, Q. (2008) Central administration of angiotensin-(1-7) stimulates nitric oxide release and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia/reperfusion in rats. Neuropeptides 42, 593-600
100. Lu, J., Zhang, Y. and Shi, J. (2008) Effects of intracerebroventricular infusion of angiotensin-(1-7) on bradykinin formation and the kinin receptor expression after focal cerebral ischemia-reperfusion in rats. Brain Res. 1219, 127-135
101. Yamamoto, E., Tamamaki, N., Nakamura, T., Kataoka, K., Tokutomi, Y., Dong, Y. F., Fukuda, M., Matsuba, S., Ogawa, H. and Kim-Mitsuyama, S. (2008) Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Stroke 39, 3049-3056
102. Li, J. M., Mogi, M., Iwanami, J., Min, L. J., Tsukuda, K., Sakata, A., Fujita, T., Iwai, M. and Horiuchi, M. (2008) Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density. Stroke 39, 2029-2036
103. Takada, J., Ibayashi, S., Ooboshi, H., Ago, T., Ishikawa, E., Kamouchi, M., Kitazono, T. and Iida, M. (2006) Valsartan improves the lower limit of cerebral autoregulation in rats. Hypertens. Res. 29, 621-626
104. Liu, H., Kitazato, K. T., Uno, M., Yagi, K., Kanematsu, Y., Tamura, T., Tada, Y., Kinouchi, T. and Nagahiro, S. (2008) Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies. J. Hypertens. 26, 1435-1445
105. Stenman, E. and Edvinsson, L. (2004) Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 35, 970-974
106. Faure, S., Bureau, A., Oudart, N., Javellaud, J., Fournier, A. and Achard, J. M. (2008) Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors. J. Hypertens. 26, 2008-2015
107. Banks, W. A. (2008) Developing drugs that can cross the blood-brain barrier: applications to alzheimer's disease. BMC Neurosci. 9 (Suppl. 3), S2
108. Sandoval, K. E. and Witt, K. A. (2008) Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol. Dis. 32, 200-219
109. Yang, G. Y., Betz, A. L., Chenevert, T. L., Brunberg, J. A. and Hoff, J. T. (1994) Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J. Neurosurg. 81, 93-102
110. Taheri, S., Candelario-Jalil, E., Estrada, E. Y. and Rosenberg, G. A. (2009) Spatiotemporal correlations between blood-brain barrier permeability and apparent diffusion coefficient in a rat model of ischemic stroke. PLoS ONE 4, e6597
111. Nagaraja, T. N., Keenan, K. A., Brown, S. L., Fenstermacher, J. D. and Knight, R. A. (2007) Relative distribution of plasma flow markers and red blood cells across BBB openings in acute cerebral ischemia. Neurol. Res. 29, 78-80
112. Nagaraja, T. N., Keenan, K. A., Fenstermacher, J. D. and Knight, R. A. (2008) Acute leakage patterns of fluorescent plasma flow markers after transient focal cerebral ischemia suggest large openings in blood-brain barrier. Microcirculation 15, 1-14
113. Gotoh, O., Asano, T., Koide, T. and Takakura, K. (1985) Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I: the time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 125I-albumin. Stroke 16, 101-109
114. Dietrich, W. D., Busto, R., Watson, B. D., Scheinberg, P. and Ginsberg, M. D. (1987) Photochemically induced cerebral infarction. II. edema and blood-brain barrier disruption. Acta Neuropathol. 72, 326-334
115. Ishii, T., Asai, T., Urakami, T. and Oku, N. (2010) Accumulation of macromolecules in brain parenchyma in acute phase of cerebral infarction/reperfusion. Brain Res. 1321, 164-168
116. Abulrob, A., Brunette, E., Slinn, J., Baumann, E. and Stanimirovic, D. (2011) In vivo optical imaging of ischemic blood-brain barrier disruption. Methods Mol. Biol. 763, 423-439
117. Nagaraja, T. N., Karki, K., Ewing, J. R., Croxen, R. L. and Knight, R. A. (2008) Identification of variations in blood-brain barrier opening after cerebral ischemia by dual contrast-enhanced magnetic resonance imaging and T 1sat measurements. Stroke 39, 427-432
118. Kulemina, L. V. and Ostrov, D. A. (2011) Prediction of off-target effects on angiotensin-converting enzyme 2. J. Biomol. Screening 16, 878-885
119. Zsila, F., Bikadi, Z., Malik, D., Hari, P., Pechan, I., Berces, A. and Hazai, E. (2011) Evaluation of drug-human serum albumin binding interactions with support vector machine aided online automated docking. Bioinformatics 27, 1806-1813
120. Bennion, D. M., Donnangelo, L., Pioquinto, D., Regenhardt, R., Raizada, M. and Sumners, C. (2013) Activation of the brain renin-angiotensin system by translational approaches following stroke onset is neuroprotective in a rat model of ischemic stroke. Stroke 44, ATP111
121. Bader, M., Santos, R. A., Unger, T. and Steckelings, U. M. (2012) New therapeutic pathways in the RAS. JRAAS 13, 505-508
122. Fraga-Silva, R. A., Costa-Fraga, F. P., De Sousa, F. B., Alenina, N., Bader, M., Sinisterra, R. D. and Santos, R. A. (2011) An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect. Clinics 66, 837-841
123. Marques, F. D., Melo, M. B., Souza, L. E., Irigoyen, M. C., Sinisterra, R. D., de Sousa, F. B., Savergnini, S. Q., Braga, V. B., Ferreira, A. J. and Santos, R. A. (2012) Beneficial effects of long-term administration of an oral formulation of angiotensin-(1-7) in infarcted rats. Int. J. Hypertens. 2012, 795452
124. Kucia, M., Jankowski, K., Reca, R., Wysoczynski, M., Bandura, L., Allendorf, D. J., Zhang, J., Ratajczak, J. and Ratajczak, M. Z. (2004) CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J. Mol. Histol. 35, 233-245
125. Hennemann, B., Ickenstein, G., Sauerbruch, S., Luecke, K., Haas, S., Horn, M., Andreesen, R., Bogdahn, U. and Winkler, J. (2008) Mobilization of CD34+ hematopoietic cells, colony-forming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. Cytotherapy 10, 303-311
126. Schwarting, S., Litwak, S., Hao, W., Bahr, M., Weise, J. and Neumann, H. (2008) Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 39, 2867-2875
127. Chen, J., Xiao, X., Chen, S., Zhang, C., Chen, J., Yi, D., Shenoy, V., Raizada, M. K., Zhao, B. and Chen, Y. (2013) Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy. Hypertension 61, 681-689